Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Canna Therapeutic ApS
APS
Bankrupt
CVR 38129562
Gymnasievej 5
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik · NACE 721900
Est. 2016
3 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2020
DKK -3,4M
-8% vs 2019
EBITDA margin
126.9%
-3% vs 2019
Equity ratio
-21.7%
Financial strength
Net profit 2020
DKK -3,9M
+11% vs 2019
EBITDA — year on year
DKK millions
0M
-1M
-3M
-4M
-5M
-1M
2017
-1M
0%
2018
-4M
-300%
2019
-4M
0%
2020
Key figures
Annual report 2020
Revenue
DKK -3,4M
-8%
EBITDA
DKK -4,4M
-3%
Net profit
DKK -3,9M
+11%
Total assets
DKK 43,6M
+21%
Equity
DKK -9,5M
-69%
Employees
3
—
Company information
Legal name
Canna Therapeutic ApS
CVR number
38129562
Legal form
Anpartsselskab
NACE code
721900 · Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Founded
12. oktober 2016
Share capital
DKK 500.000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller af den samlede direktion
Contact
Address
Gymnasievej 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Companies in Egedal
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
-1M
2017
0M
2018
-4M
2019
-3M
2020
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
-1M
2017
-1M
2018
-4M
2019
-4M
2020
Income statement
DKK thousands
Item
2017
2018
2019
2020
Revenue
-569
-133
-3.744
-3.449
Staff expenses
-864
-987
-518
-704
EBITDA
-1.433
-1.121
-4.262
-4.376
Depreciation & amort.
-174
-133
-144
-516
EBIT
-1.607
-1.254
-4.407
-4.892
Net financials
-1
-2
-1.162
-65
Profit before tax
-1.608
-1.256
-5.568
-4.957
Tax
-353
-275
-1.220
-1.082
Net profit
-1.254
-981
-4.348
-3.875
Balance sheet
DKK thousands
Item
2017
2018
2019
2020
Total assets
989
765
35.934
43.572
Equity
-254
-1.235
-5.584
-9.459
Long-term debt
0
0
202
346
Short-term debt
1.244
2.000
37.949
50.399
Total debt
1.244
2.000
38.150
50.746
Financial ratios
5-year trend
EBITDA margin
-437586500.0%
This company
15.8%
Market median
-2769534910% vs market
2017
2020
Equity ratio
-21.7%
This company
38.2%
Market median
-157% vs market
2017
2020
Return on equity
-387526300.0%
This company
18.4%
Market median
-2106121296% vs market
2017
2020
Net profit margin
-387526300.0%
This company
8.1%
Market median
-4784275409% vs market
2017
2020
Asset turnover
-0.08×
This company
1.12×
Market median
-107% vs market
2017
2020
Debt / equity
5.61×
This company
0.62×
Market median
-805% vs market
2017
2020
Annual reports & filings
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2016-10-12 – 2017-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
SP
Steen Plesner Pontoppidan
Chief Executive Officer
Chief Executive Officer
2016 – 2021
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
CBD-International ApS
Company
50–66.65%
50–66.65%
2017
MSVISION ApS
Company
50–66.65%
50–66.65%
2016
MS INCUBATOR ApS
Company
50–66.65%
50–66.65%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Canna Therapeutic ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Steen Plesner Pontoppidan
Chief Executive Officer
0 companies